Inside the discovery of semaglutide
US$ 23.11
retatrutide weight loss trials Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide vs CagriSema: The Battle
Description
GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) act on the brain as well as the gut, and a 2026 real-world cohort study from Kamel-Abusalha et a
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.
Not for under-18s, pregnant or breastfeeding women, or those sensitive to caffeine
Liraglutide (NN2211) is a long-acting GLP-1 receptor agonist used to treat type 2 diabetes and obesity (Victoza, Saxenda)
Learn how to manage nausea, dry mouth, and constipation while on weight loss injections.
